CEO of Novo Nordisk on potential successors: "I've only just begun"
At the start of 2022, Lars Fruergaard Jørgensen enters his fifth year as CEO of Novo Nordisk. While talent is being nurtured in the organization, his successor might have a long time to wait.
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
The next-in-line to the throne of Denmark's most valuable company, Novo Nordisk, might not even have made it to the executive management level yet, says its current CEO, Lars Fruergaard Jørgensen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
